Mov Disord Vol 37, Suppl 2 Archives - Page 50 of 153 - MDS Abstracts

2022 International Congress
IPX203 dose conversion from immediate-release carbidopa-levodopa, in Parkinson’s disease patients with motor fluctuations.
R. Hauser, A. Espay, W. Ondo, B. Safirstein, H. Moore, R. Kumar, G. Banisadr, S. Fisher (Tampa, USA)
Objective: To analyze dosing regimen data from a Phase 3 study in order to identify an optimal dose conversion from IR CD-LD to IPX203 for…
2022 International Congress
Correlation between clinical scales and gait in Parkinson’s disease
A. Bitiati, C. de Oliveira, R. Treza, S. Hondo, E. Angeles, C. Bernardo, L. de Oliveira, M. Carvalho, M. Golin, D. Coelho (Santo André, Brazil)
Objective: The objective of this study is to verify the correlations between cognitive and motor clinical scales and gait in individuals with PD and whether…
2022 International Congress
Prospective, Multicenter, Real-World Outcomes Study with Directional Deep Brain Stimulation Systems in the Treatment of Parkinson’s Disease
M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, J. Ramirez-Castaneda, J. Carlson, J. Aldred, V. Krishna, A. Merola, C. Luca, J. Jagid, J. Durphy, L. Verhagen-Metman, S. Sani, S. Ojemann, D. Kern, D. Weintraub, R. Ramdhani, A. Siadati, B. Sundaram, C. Zhao, D. Martinez, M. Siddiqui, S. Tatter, J. Wang, R. Jain (Gainesville, USA)
Objective: We present preliminary outcomes from an ongoing prospective, on-label, multicenter outcomes study conducted in the United States of patients with directional Deep Brain Stimulation…
2022 International Congress
Comparison of efficacy and safety of adjunct treatments to levodopa in patients with Parkinson’s disease and wearing-off: A network meta-analysis of randomized, double-blind trials
Y. Kogo, W. Sako, M. Koebisu, H. Yamakage, T. Ishida, N. Hattori (Tokyo, Japan)
Objective: To determine the rankings for efficacy and tolerability of levodopa adjuncts in patients with Parkinson’s disease (PD) and wearing-off by network meta-analysis. Background: When…
2022 International Congress
Remote Assessment of Tremor using Wearable Sensors in Parkinson’s Disease Research
M. Pawlik, K. Dinesh, S. Jensen-Roberts, E. Waddell, T. Myers, J. Soto, E. Hartman, E. Nnadika, P. Yang, R. Yuan, G. Sharma, R. Wilson, K. Lizarraga, C. Tarolli, R. Schneider, R. Dorsey, J. Adams (Rochester, USA)
Objective: To describe wearable sensor-derived measures in Parkinson’s disease (PD) research. Background: Many commonly used outcome measures of PD are subjective, rater dependent, and infrequently…
2022 International Congress
Remission of Gilles de la Tourette Syndrome Following Dehydration
A. Durbin, M. Rodgers, J. Brasic, D. Wong (Baltimore, USA)
Objective: To assess the beneficial and adverse effects of heat on a man with Gilles de la Tourette Syndrome (TS) Background: The effect of heat…
2022 International Congress
Feasibility of Sensor-Based Music Feedback In Patients With PD
S. Mainka, G. Ebersbach (Beelitz-Heilstaetten, Germany)
Objective: To assess the feasibility of sensor-based music feedback (SBMF) to improve arm swing (AS) and other gait parameters in patients with PD. Background: Reduction…
2022 International Congress
Pan India Registry for Progressive Supranuclear Palsy (PAIR-PSP)
P. Kukkle, R. Gupta, S. Desai, S. Mehta, D. Joshi, N. Kumar, R. Kandadai, L. Sahoo, A. Mukherjee, V. Paramanandam, S. Murugan, D. Kp, S. Sundaram, R. Rajan, R. Menon, K. Shetty, P. Samson, S. Krishnan, M. Deshmukh, P. Wadia, C. Sandeep, P. Aggarwal, S. Bhowmick, H. Kumar, A. Biswas, V. Goyal, S. Seshagiri, R. Borgohain, V. Ramprasad (Bangalore, India)
Objective: To understand Progressive Supranuclear palsy (PSP) phenotype and genotype from India. Background: Insights into PSP pathophysiology and newer clinical phenotypes are increasingly being recognized.…
2022 International Congress
Therapies, Research Funding and Racial Diversity in Essential Tremor: A Systematic Review of the Literature
T. Zesiewicz, J. Vega, C. Gooch, S. Ghanekar, Y. Huang, Y. Bezchlibnyk, J. Staffettiij, C. Kingsbury (Tampa, USA)
Objective: To analyze controlled clinical trials in essential tremor (ET) spanning the last 50 years in order to identify potential shortcomings in the therapeutic clinical…
2022 International Congress
The influence of GBA and LRRK2 on mood disorders in Parkinson’s Disease
A. Thaler, N. Omer, B. Cohen, N. Giladi, M. Kestenbaum, J. Shirvan, J. Cedarbaum, M. Gana-Weisz, O. Goldstein, A. Orr-Urtreger, A. Mirelman (Tel-Aviv, Israel)
Objective: To assess the influence of mutations in the LRRK2 and GBA genes on mood disorders among patients with Parkinson's disease (PD) Background: Mood disorders…